New report details capital investment and operating costs of an Acrylic Acid Plant

New report details capital investment and operating costs of a Butadiene Plant

Enabling individuals to calculate and track the Glucose-Ketone Index alongside all other vital health metrics

New report details capital investment and operating costs of a Lactic Acid Plant

Dimpflmeier Bakery Ltd. announces the release of their new CARB SMART™ bread, the world's first commercially available high-protein, ultra-low net carb all-natural bread that promises to satisfy both athletes and foodies.

New reports evaluate the economic feasibility of manufacturing PEF

New report details capital investment and operating costs of a Bio-Butanediol Plant

New report details capital investment and operating costs of a 2,5-Furandicarboxylic Acid plant

Cataract is one of diabetes complications. The Glucose Tolerance Factor (GTF), a yeast derived anti-diabetic substance, was examined on diabetic cataractogenesis. 15 oral doses of GTF administered to diabetic rats inhibited cataract formation in their eyes. Incubation of bovine lenses in high glucose medium decreased their optical quality. When GTF was added to high glucose medium this damage was prevented. This study presents GTF as a potent anti-cataract agent both in vivo and in vitro.

Come celebrate ARC Walk-In Clinic and Applied Research Center of Arkansas' grand re-opening on April 27, 2016 from 8am to 6pm where attendees can receive free blood pressure and blood glucose checks, meet the staff, tour the facility and pick up some giveaways to take home!

Manchester, NH-based Boston Therapeutics developing a chewable pill designed to be taken before meals to lower the elevation of blood glucose after the meal.

After completing the clinical trial on over 30 patients with effectiveness at 100%, Sino Stem Cells, introduces diabetes clinically. 62.9% reduced insulin dosage by 50%. 3.7% of Type 1 and 11.1% of Type 2 could completely stop insulin injections.